Biogen Ups Samsung Bioepis Stake In $700m Bet On Biosimilars

 
• By Jung Won Shin
  
Call option
Biogen exercises call option in Samsung Bioepis • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from South Korea

More from Focus On Asia